PCM
MIRM icon

Penserra Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Penserra Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$789K Buy
+6,748
New +$678K 0.01% 523
2026
Q1 		– Sell
-20,128
Closed -$1.59M – 1153
2025
Q4 		$1.59M Sell
20,128
-6,351
-24% -$456K 0.02% 350
2025
Q3 		$1.94M Buy
26,479
+18,746
+242% +$1.19M 0.02% 340
2025
Q2 		$393K Buy
+7,733
New +$344K 0.01% 550
2024
Q3 		– Sell
-26,906
Closed -$920K – 1237
2024
Q2 		$920K Buy
+26,906
New +$705K 0.01% 445

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Penserra Capital Management's MIRM Position: Q2 2026 in Review

Penserra Capital Management opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 6,748 shares worth $789K. The stake represents 0.01% of the portfolio and ranks #523 among its holdings. This is a return to the name: Penserra Capital Management previously reported a position in MIRM as recently as Q4 2025.

Penserra Capital Management first reported a position in MIRM in Q2 2024 and has held it in 5 quarters since. The position peaked at $1.94M in Q3 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Penserra Capital Management held 6,748 shares of Mirum Pharmaceuticals worth $789K as of Q2 2026.
  • Mirum Pharmaceuticals was a new Penserra Capital Management position in Q2 2026.
  • Mirum Pharmaceuticals made up 0.01% of Penserra Capital Management's portfolio in Q2 2026, its #523 holding.
  • Penserra Capital Management first reported a position in Mirum Pharmaceuticals in Q2 2024 and has held it in 5 quarters since.
  • Penserra Capital Management's Mirum Pharmaceuticals position peaked at $1.94M in Q3 2025.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.